This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Xenon Pharmaceuticals Inc., Xenox Pharmaceuticals Inc.. Active years: 2010-2026.
Company Filing History:
Years Active: 2010-2026
Title: Innovator Spotlight: Robin Sherrington - Pioneering Pain Management Solutions
Introduction:
Meet Robin Sherrington, a brilliant inventor hailing from North Vancouver, CA. With an impressive portfolio of 4 patents to his name, Sherrington's work in the field of pain management has garnered significant attention.
Latest Patents:
Sherrington's groundbreaking inventions revolve around identifying analgesic agents. His latest patents focus on the discovery that mutations in SCN9A are responsible for Congenital Indifference to Pain (CIP) in humans. These patents outline innovative methods using small organic compounds to treat pain, predict the effects of analgesic agents, and screen for therapeutic treatments selective for SCN9A.
Career Highlights:
Sherrington has made substantial contributions to the pharmaceutical industry through his work with companies like Xenon Pharmaceuticals Inc. and Xenox Pharmaceuticals Inc. His expertise and dedication to advancing pain management solutions have positioned him as a trailblazer in the field.
Collaborations:
Throughout his career, Sherrington has collaborated with esteemed professionals such as Marcia MacDonald and Mark E. Samuels. These partnerships have been instrumental in driving forward his research and development efforts.
Conclusion:
In conclusion, Robin Sherrington stands out as a visionary inventor in the realm of pain management. His innovative approach to identifying analgesic agents has the potential to revolutionize healthcare practices and improve the quality of life for countless individuals. Sherrington's commitment to innovation serves as an inspiration to aspiring inventors and researchers in the field.